BE893559A - Traitement d'affections arthritiques - Google Patents

Traitement d'affections arthritiques

Info

Publication number
BE893559A
BE893559A BE0/208382A BE208382A BE893559A BE 893559 A BE893559 A BE 893559A BE 0/208382 A BE0/208382 A BE 0/208382A BE 208382 A BE208382 A BE 208382A BE 893559 A BE893559 A BE 893559A
Authority
BE
Belgium
Prior art keywords
treatment
arthritic conditions
arthritic
conditions
Prior art date
Application number
BE0/208382A
Other languages
English (en)
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of BE893559A publication Critical patent/BE893559A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE0/208382A 1981-06-19 1982-06-18 Traitement d'affections arthritiques BE893559A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8119006 1981-06-19

Publications (1)

Publication Number Publication Date
BE893559A true BE893559A (fr) 1982-12-20

Family

ID=10522661

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/208382A BE893559A (fr) 1981-06-19 1982-06-18 Traitement d'affections arthritiques

Country Status (8)

Country Link
US (1) US4397867A (fr)
EP (1) EP0068314A1 (fr)
JP (1) JPS5823619A (fr)
BE (1) BE893559A (fr)
IT (1) IT8248659A0 (fr)
NZ (1) NZ201010A (fr)
PH (1) PH18342A (fr)
ZA (1) ZA824327B (fr)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE34313E (en) * 1983-09-23 1993-07-13 National Research Development Corporation Pharmaceutical compositions
US4912118A (en) * 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
US5177068A (en) * 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
US4863964A (en) * 1985-07-02 1989-09-05 Biomedical Frontiers, Inc. Method for the stabilization of deferoxamine to chelate free ions in physiological fluid
US5217998A (en) * 1985-07-02 1993-06-08 Biomedical Frontiers, Inc. Composition for the stabilization of deferoxamine to chelate free ions in physiological fluid
EP0214101A3 (fr) * 1985-09-03 1989-05-31 Ciba-Geigy Ag Utilisation des fer(III) chelateurs du type desferrioxamine-B et desferriferrithiocine pour le traitement du paludisme
US4599361A (en) * 1985-09-10 1986-07-08 G. D. Searle & Co. Hydroxamic acid based collagenase inhibitors
US4743587A (en) * 1985-09-10 1988-05-10 G. D. Searle & Co. Hydroxamic acid based collagenase inhibitors
US4698431A (en) * 1985-11-12 1987-10-06 The United States Of America As Represented By The United States Department Of Energy Hydroxypyridonate chelating agents
EP0227593A1 (fr) * 1985-11-25 1987-07-01 The Hospital For Sick Children Application d'agents chélatants
US4797285A (en) * 1985-12-06 1989-01-10 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Lipsome/anthraquinone drug composition and method
US5672334A (en) * 1991-01-16 1997-09-30 Access Pharmaceuticals, Inc. Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans
US5707604A (en) * 1986-11-18 1998-01-13 Access Pharmaceuticals, Inc. Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles
US5043166A (en) * 1987-01-09 1991-08-27 Hadasit Medical Research, Inc. Liposome/anthraquinone drug composition and method
US6099856A (en) 1992-06-15 2000-08-08 Emisphere Technologies, Inc. Active agent transport systems
US5629020A (en) * 1994-04-22 1997-05-13 Emisphere Technologies, Inc. Modified amino acids for drug delivery
US6221367B1 (en) 1992-06-15 2001-04-24 Emisphere Technologies, Inc. Active agent transport systems
US5578323A (en) 1992-06-15 1996-11-26 Emisphere Technologies, Inc. Proteinoid carriers and methods for preparation and use thereof
US5714167A (en) 1992-06-15 1998-02-03 Emisphere Technologies, Inc. Active agent transport systems
US6331318B1 (en) 1994-09-30 2001-12-18 Emisphere Technologies Inc. Carbon-substituted diketopiperazine delivery systems
US5447728A (en) * 1992-06-15 1995-09-05 Emisphere Technologies, Inc. Desferrioxamine oral delivery system
US5693338A (en) 1994-09-29 1997-12-02 Emisphere Technologies, Inc. Diketopiperazine-based delivery systems
US5811127A (en) 1992-06-15 1998-09-22 Emisphere Technologies, Inc. Desferrioxamine oral delivery system
US5792451A (en) 1994-03-02 1998-08-11 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
US5401516A (en) 1992-12-21 1995-03-28 Emisphere Technologies, Inc. Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
US5643957A (en) 1993-04-22 1997-07-01 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5709861A (en) 1993-04-22 1998-01-20 Emisphere Technologies, Inc. Compositions for the delivery of antigens
US5958457A (en) 1993-04-22 1999-09-28 Emisphere Technologies, Inc. Compositions for the delivery of antigens
JP4361601B2 (ja) 1993-04-22 2009-11-11 エミスフェアー・テクノロジーズ・インク 経口薬剤移送組成物およびその方法
CA2164957A1 (fr) * 1993-06-14 1994-12-22 Sam J. Milstein Excipient a base de protenoides; methode de preparation et utilisation
CA2101241C (fr) * 1993-07-23 1998-12-22 Jonathan P. Wong Ciprofloxacine encapsulee dans des liposomes
US6001347A (en) 1995-03-31 1999-12-14 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5965121A (en) 1995-03-31 1999-10-12 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5650386A (en) 1995-03-31 1997-07-22 Emisphere Technologies, Inc. Compositions for oral delivery of active agents
US5866536A (en) 1995-03-31 1999-02-02 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
BR9604880A (pt) 1995-03-31 1998-05-19 Emisphere Tech Inc Composto composição forma de unidade de dosagem métodos para administração de um agente biologicamente ativo para preparar uma composição para administração de um agente ativo e para preparar um composto e composição farmacológica
US5989539A (en) 1995-03-31 1999-11-23 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6090958A (en) 1995-03-31 2000-07-18 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5820881A (en) 1995-04-28 1998-10-13 Emisphere Technologies, Inc. Microspheres of diamide-dicarboxylic acids
US5824345A (en) 1995-06-07 1998-10-20 Emisphere Technologies, Inc. Fragrances and flavorants
US5667806A (en) 1995-06-07 1997-09-16 Emisphere Technologies, Inc. Spray drying method and apparatus
US5750147A (en) 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
US6051258A (en) 1995-06-07 2000-04-18 Emisphere Technologies, Inc. Proteinoid emulsions and methods for preparation and use thereof
US6106866A (en) * 1995-07-31 2000-08-22 Access Pharmaceuticals, Inc. In vivo agents comprising cationic drugs, peptides and metal chelators with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles, including tumor sites
DE19681560T1 (de) 1995-09-11 1998-08-20 Emisphere Tech Inc Verfahren zur Herstellung von omega-Aminoalkansäure-Derivaten aus Cycloalkanonen
EP0904065A4 (fr) 1996-06-14 2000-06-14 Emisphere Tech Inc Parfums microencapsules et leur procede de production
US6313088B1 (en) 1997-02-07 2001-11-06 Emisphere Technologies, Inc. 8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents
US5804688A (en) 1997-02-07 1998-09-08 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5939381A (en) 1997-02-07 1999-08-17 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6060513A (en) 1997-02-07 2000-05-09 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6358504B1 (en) 1997-02-07 2002-03-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5990166A (en) 1997-02-07 1999-11-23 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5876710A (en) 1997-02-07 1999-03-02 Emisphere Technologies Inc. Compounds and compositions for delivering active agents
US5879681A (en) 1997-02-07 1999-03-09 Emisphere Technolgies Inc. Compounds and compositions for delivering active agents
US5863944A (en) 1997-04-30 1999-01-26 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5962710A (en) 1997-05-09 1999-10-05 Emisphere Technologies, Inc. Method of preparing salicyloylamino acids
US8029795B2 (en) * 1999-12-30 2011-10-04 Gwathmey, Inc. Targeted iron chelator delivery system
CA2733819A1 (fr) * 1999-12-30 2001-07-12 Judith K. Gwathmey Systeme de distribution de chelateur de fer
US9737511B2 (en) * 2004-05-24 2017-08-22 Geoffrey C. GURTNER Method of treating or preventing pathologic effects of acute increases in hyperglycemia and/or acute increases of free fatty acid flux
US10098857B2 (en) 2008-10-10 2018-10-16 The Board Of Trustees Of The Leland Stanford Junior University Topical and transdermal delivery of HIF-1 modulators to prevent and treat chronic wounds
NZ703532A (en) * 2012-07-05 2018-02-23 Taiwan Liposome Co Ltd Methods of treating arthritis
EP3922241B1 (fr) 2013-02-01 2023-11-15 Celator Pharmaceuticals, Inc. Chargement à distance de médicaments médiocrement solubles dans l'eau dans des liposomes
EP3177269A4 (fr) 2014-08-04 2018-02-28 Zoneone Pharma, Inc. Chargement à distance de médicaments modérément hydrosolubles dans des vésicules lipidiques
US11331288B2 (en) 2017-09-14 2022-05-17 The Board Of Trustees Of The Leland Stanford Junior University Conditioning irradiated tissue for increasing vascularity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB999583A (en) * 1959-09-25 1965-07-28 Ciba Ltd Pharmaceutical preparations containing trihydroxamic acids

Also Published As

Publication number Publication date
IT8248659A0 (it) 1982-06-17
NZ201010A (en) 1986-02-21
JPS5823619A (ja) 1983-02-12
US4397867A (en) 1983-08-09
ZA824327B (en) 1984-01-25
PH18342A (en) 1985-06-05
EP0068314A1 (fr) 1983-01-05

Similar Documents

Publication Publication Date Title
BE893559A (fr) Traitement d'affections arthritiques
DE3585981D1 (de) Behandlung gewebedegenerativer entzuendungskrankheiten.
BE890648A (fr) Compositions pour le traitement de l'acne
ES510042A0 (es) "un procedimiento de preparacion de nuevas carboxamidas heterociclicas".
FR2507867B1 (fr) Procede de preparation de l'a-glycosylglycyrrhizine et applications de celle-ci
BE896285A (fr) Traitement de materiaux particulaires
SE8300912D0 (sv) Kompositioner for behandling av glaukom
BE895268A (fr) Traitement des bains d'electrodeposition
BE884537A (fr) Traitement des effluants de carbonylation
SE8300913D0 (sv) Kompositioner for behandling av glaukom
FR2558372B1 (fr) Composition medicamenteuse pour le traitement de l'acne
IT8420682A1 (it) "Procedimento per il trattamento di articoli di maglieria"
FR2433978B1 (fr) Traitement d'algues
RO88351A3 (fr) Composition pour le traitement des affections gastroduodenales
BE894228A (fr) Composition pharmaceutique pour le traitement de l'atherosclerose
FR2573088B1 (fr) Procede de traitement des vinasses
FR2519269B1 (fr) Chambre pour traitement experimental d'animaux et de plantes
BE892339A (fr) Agents pour le traitement d'affections cardiaques coronariennes
FR2588756B1 (fr) Composition pour le traitement des cheveux
FR2517203B1 (fr) Composition pour le traitement de l'acne
FR2562798B1 (fr) Agent pharmaceutique pour le traitement du psoriasis
IT1192483B (it) Kanamicine 2'-modificate e produzione di queste
SE8503064D0 (sv) Behandling av radioaktivt avfall
BE894154A (fr) Procede de preparation d'esters des acides alkoxyvincaminiques et alkoxyapovincaminiques
BE893929A (fr) Procede de purification de l'hydrate de titanyle

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: CIBA-GEIGY A.G.

Effective date: 19860630